Beijing, China

Wuyan Zhang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wuyan Zhang. Retrieved from https://idiyas.com/inventor/wuyan-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wuyan Zhang: Innovator in Pharmaceutical Science

Introduction

Wuyan Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative research and development of new compounds.

Latest Patents

Wuyan Zhang holds a patent for "Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine." This patent describes a compound represented by a specific formula, detailing the substitutes defined in the specification and claims, as well as their stereoisomers. The patent also outlines the process for preparing these compounds and their applications in medicine.

Career Highlights

Wuyan Zhang is affiliated with the Chinese Academy of Medical Sciences, where he has been involved in groundbreaking research. His work focuses on developing new pharmaceutical compositions that can potentially improve medical treatments.

Collaborations

Throughout his career, Wuyan Zhang has collaborated with notable colleagues, including Jiyu Guo and Qian Jack Liu. These partnerships have enhanced his research efforts and contributed to the advancement of pharmaceutical sciences.

Conclusion

Wuyan Zhang's innovative work in the field of pharmaceuticals exemplifies the importance of research and development in medicine. His contributions continue to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…